Aubrey Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,651
| Closed | -$231K | – | 53 |
|
|
2023
Q1 | $231K | Hold |
5,651
| – | – | 0.13% | 45 |
|
|
2022
Q4 | $218K | Hold |
5,651
| – | – | 0.17% | 42 |
|
|
2022
Q3 | $301K | Hold |
5,651
| – | – | 0.26% | 37 |
|
|
2022
Q2 | $329K | Sell |
5,651
-1,245
| -18% | -$72.6K | 0.27% | 40 |
|
|
2022
Q1 | $526K | Buy |
6,896
+600
| +10% | +$45.8K | 0.3% | 38 |
|
|
2021
Q4 | $379K | Hold |
6,296
| – | – | 0.15% | 29 |
|
|
2021
Q3 | $353K | Hold |
6,296
| – | – | 0.11% | 33 |
|
|
2021
Q2 | $382K | Hold |
6,296
| – | – | 0.11% | 33 |
|
|
2021
Q1 | $441K | Hold |
6,296
| – | – | 0.12% | 37 |
|
|
2020
Q4 | $377K | Buy |
+6,296
| New | +$377K | 0.09% | 37 |
|